Amedisys Inc (AMED)
Current ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 632,083 | 579,947 | 555,902 | 526,448 | 496,935 | 467,227 | 426,544 | 405,557 | 388,961 | 388,780 | 394,869 | 392,485 | 356,684 | 432,882 | 390,965 | 380,450 | 361,984 | 411,250 | 449,540 | 468,128 |
| Total current liabilities | US$ in thousands | 514,392 | 486,021 | 479,976 | 484,860 | 473,721 | 468,119 | 462,401 | 353,050 | 355,529 | 367,200 | 427,372 | 380,154 | 374,282 | 454,349 | 449,223 | 456,082 | 456,337 | 437,496 | 442,048 | 316,106 |
| Current ratio | 1.23 | 1.19 | 1.16 | 1.09 | 1.05 | 1.00 | 0.92 | 1.15 | 1.09 | 1.06 | 0.92 | 1.03 | 0.95 | 0.95 | 0.87 | 0.83 | 0.79 | 0.94 | 1.02 | 1.48 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $632,083K ÷ $514,392K
= 1.23
Amedisys Inc's current ratio, which measures the company's ability to cover its short-term liabilities with its current assets, has fluctuated over the reporting periods provided. The current ratio stood at 1.48 as of March 31, 2020, indicating a strong ability to meet short-term obligations. However, the ratio declined to 0.79 by December 31, 2020, suggesting potential liquidity challenges.
Subsequently, there was a trend of improvement in the current ratio, reaching a peak of 1.23 by December 31, 2024. This upward trend indicates a better ability to cover short-term liabilities with current assets, reflecting improved liquidity and financial health during this period.
Overall, it is essential for stakeholders to closely monitor Amedisys Inc's current ratio to assess its short-term liquidity position and ability to meet obligations as the company's performance in this aspect has varied significantly over the reporting periods.
Peer comparison
Dec 31, 2024